Medivolve Announces Investment Into Marvel Diagnostics and Its Non-Invasive Exhaled Breath Diagnostic Technology
Marvel Diagnostics innovative BlowFISH technology offers the potential for a a simple,
inexpensive, non-invasive, massively-deployable, rapid diagnostic or sentinel system for detecting respiratory illness and airborne viral threats.